COMP <GO>
ESNT vs BRK-B // PIOTROSKI F-SCORE QUALITY
Essent Group Ltd. (NYSE) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: ESNT 10
— BRK-B 4
▲ PIOTROSKI F-SCORE QUALITY LEADER: ESNT
LAST: $67.02 (-0.86%) • MKT CAP: $6.08B
piotroski-score
7/9
LAST: $542.49 (+0.10%) • MKT CAP: $1.16T
piotroski-score
4/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ESNT VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ESNT | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.90% | 11.47% | +0.43 | ESNT | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.9x | 9.7x | -2.78 | ESNT | /valuation <GO> |
| Free Cash Flow Yield | 13.97% | 2.09% | +11.88 | ESNT | /fcf-yield <GO> |
| Operating Margin | 66.80% | 27.80% | +39.00 | ESNT | /operating-margins <GO> |
| Net Profit Margin | 54.70% | 22.30% | +32.40 | ESNT | /net-margins <GO> |
| Revenue Growth (YoY) | 1.50% | 3.93% | -2.43 | BRK-B | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.01% | 0.00% | +2.01 | ESNT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.05 | 2.85 | +1.20 | ESNT | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 7/9 | 4/9 | +3.00 | ESNT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 3.55% | +3.25 | BRK-B | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.1 | 66.8 | -8.69 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.96 | 0.61 | +0.35 | ESNT | /macro-sensitivity <GO> |
| Forward P/E Multiple | 8.2x | 24.3x | -16.14 | ESNT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.08B | $1.16T | -$1.15T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ESNT REV | BRK-B REV | ESNT GROSS % | BRK-B GROSS % | ESNT FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.26B | $371.44B | 44.0% | — | $848.7M | $25.04B |
| FY 2024 | $1.24B | $371.43B | 44.0% | — | $854.8M | $11.62B |
| FY 2023 | $1.11B | $364.48B | 44.0% | — | $713.1M | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ESNT // BETA 0.96
BRK-B // BETA 0.61